Urinary dicarboxylic acids in patients receiving lithium or rubidium salts.
Lithium salts administered in therapeutic doses to four subjects who were kept on controlled diets increased up to fivefold the urinary output of some dicarboxylic acids. Some of the acids affected are intermediates in the tricarboxylic acid cycle, others are chemically similar but not directly related in metabolic terms. This is probably a direct effect on renal transport. Rubidium salts increased urinary 2-oxoglutarate output and blood 2-oxoglutarate levels, probably by some action on intermediary metabolism.
D001714:Bipolar Disorder / Q000188:drug therapy; D003998:Dicarboxylic Acids / Q000652:urine*; D004912:Erythrocytes / Q000378:metabolism; D006801:Humans; D007656:Ketoglutaric Acids / Q000652:urine; D008094:Lithium / Q000494:pharmacology* / Q000627:therapeutic use; D012413:Rubidium / Q000494:pharmacology* / Q000627:therapeutic use
D003998:Dicarboxylic Acids; D007656:Ketoglutaric Acids; D008094:Lithium; D012413:Rubidium